Shearman & Sterling represented the International Chemical Investors Group, a German-based industrial holding company, when its wholly owned subsidiary, Corden Pharma S.p.A., completed a June 30 asset purchase agreement whereby it purchased the entire production business of the AstraZeneca Group in Italy. With over 400 employees and revenues of approximately €80 million, the business is a major producer of Diprivan, an anesthetic.

Principal attorneys involved in the transaction included partners Domenico Fanuele (Rome-Mergers & Acquisitions) and Silvio Cappellari (Brussels-Antitrust), counsel Deborah Lincoln (London-Mergers & Acquisitions), associates Tommaso Tosi (Rome-Mergers & Acquisitions), Emi Landan (London-Mergers & Acquisitions), Giovanni Cirelli (Rome-Mergers & Acquisitions) and Francesco Liberatori (Rome-Mergers & Acquisitions) and international trainee Matteo Melis (Rome-Mergers & Acquisitions).